Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 18, Issue 4, 2011, Pages 551-558

  Tang, Yu ^a   Liao, Yonghui ^b   Kawaguchi Sakita, Nobuko ^d   Raut, Vikram ^d   Fakhrejahani, Elham ^d   Qian, Niansong ^c   Toi, Masakazu ^d  

^a BEIJING 302 HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Chronic pancreatitis; Sinisan; Traditional chinese medicine; Trinitrobenzene sulfonic acid

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMYLASE; ANALGESIC AGENT; ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; NERVE GROWTH FACTOR; SINISAN; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; AMYLASE BLOOD LEVEL; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CHINESE MEDICINE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; GENE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INTERLEUKIN 10 GENE; INTERLEUKIN 1BETA GENE; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; TREATMENT DURATION; TUMOR NECROSIS FACTOR ALPHA GENE; UPREGULATION;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; INTERLEUKIN-10; INTERLEUKIN-1BETA; PANCREAS; PANCREATITIS, CHRONIC; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052679401     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-010-0368-z     Document Type: Article

References (38)

1. Zhao HF, Ito T, Gibo J, Kawabe K, Oono T, Kaku T, et al. Antimonocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Gut. 2005;54:1759-67. (Pubitemid 41697676)
2. Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Dev. 2010;13:50-65.
3. Jiang J, Zhou C, Xu Q. Alleviating effects of si-ni-san, a traditional Chinese prescription, on experimental liver injury and its mechanisms. Biol Pharm Bull. 2003;26:1089-94. (Pubitemid 40012570)
4. Sun Y, Chen T, Xu Q. Si-Ni-San, a traditional Chinese prescription, and its drug-pairs suppress contact sensitivity in mice via inhibition of the activity of metalloproteinases and adhesion of T lymphocytes. J Pharm Pharmacol. 2003;55:839-46. (Pubitemid 36752728)
5. Sun Y, Dong Y, Jiang HJ, Cai TT, Chen L, Zhou X, et al. Dissection of the role of paeoniflorin in the traditional Chinese medicinal formula Si-Ni-San against contact dermatitis in mice. Life Sci. 2009;84:337-44.
6. Ohta Y, Kobayashi T, Nishida K, Nagata M, Ishiguro I. Therapeutic effect of Oren-gedoku-to extract on stress-induced acute gastric mucosal lesions in rats. Phytother Res. 1999;13:588-92. (Pubitemid 29520936)
7. Ohta Y, Kobayashi T, Hayashi T, Inui K, Yoshino J, Nakazawa S. Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Phytother Res. 2006;20:256-62.
8. Sun Y, Cai TT, Shen Y, Zhou XB, Chen T, Xu Q. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance. Int Immunopharmacol. 2009;9:1437-43.
9. Gironella M, Iovanna JL, Sans M, Gil F, Peñalva M, Closa D, et al. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut. 2005;54:1244-53. (Pubitemid 41192482)
10. Triantafillidis JK, Cheracakis P, Hereti IA, Argyros N, Karra E. Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment. Am J Gastroenterol. 2000;95:3334-6.
11. Akgü l S, Erbil Y, Giris M, Alis H, Yanik BT, Olgaç V, et al. The effect of octreotide on pancreatic damage in TNBS-induced colitis. Surg Innov. 2006;13:102-8. (Pubitemid 44219519)
12. Feng QX, Wang W, Feng XY, Mei XP, Zhu C, Liu ZC, et al. Astrocytic activation in thoracic spinal cord contributes to persistent pain in rat model of chronic pancreatitis. Neuroscience. 2010;167:501-9.
13. Puig-Divi V, Molero X, Vaquero E, Salas A, Guarner F, Malagelada J. Ethanol feeding aggravates morphological and biochemical parameters in experimental chronic pancreatitis. Digestion. 1999;60:166-74. (Pubitemid 29142032)
14. Wang J, Li Q. Study on the effect of 100 chronic pancreatitis patients treated by Sinisan. Chin J Pract Int Med. 2008;22:38 (in Chinese).
15. Dong XF, Hu XP. Study on the effect of 18 chronic pancreatitis patients treated by Sinisan. Pract Clin J Integr Tradit Chin West Med. 2007;7:94 (in Chinese).
16. Dong XF, Hu XP. Therapeutic effect of Sinisan on 18 chronic pancreatitis patients. Chin J Clin Med Prog Res. 2007;13:661 (in Chinese).
17. Bartel M, Hänsch GM, Giese T, Penzel R, Ceyhan G, Ketterer K, et al. Abnormal crosstalk between pancreatic acini and macrophages during the clearance of apoptotic cells in chronic pancreatitis. J Pathol. 2008;215:195-203. (Pubitemid 351786038)
18. Daniel P, Mokrowiecka A, Gasiorowska A, Małecka-Panas E. Tumor necrosis factor alpha (TNF-alpha) and its receptors: sTNF-alphaRI i sTNF-alphaRII in chronic pancreatitis. Pol Arch Med Wewn. 2005;114:639-43. (Pubitemid 46118111)
19. Marrache F, Tu SP, Bhagat G, Pendyala S, Osterreicher CH, Gordon S, et al. Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis. Gastroenterology. 2008;135:1277-87.
20. Koliopanos A, Friess H, Kleeff J, Roggo A, Zimmermann A, Büchler MW. Cyclooxygenase 2 expression in chronic pancreatitis: correlation with stage of the disease and diabetes mellitus. Digestion. 2001;64:240-7. (Pubitemid 34158331)
21. Qian NS, Xu XP, Chen Y, Dou KF, Wang YY, Yang YL. Protective effect of cyclosporin A on brain injury in rats with acute necrotic pancreatitis. Life Sci. 2010;87:64-8.
22. Demols A, Van Laethem JL, Quertinmont E, Degraef C, Delhaye M, Geerts A, et al. Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2002;282:G1105-12. (Pubitemid 34651617)
23. Winston JH, Toma H, Shenoy M, He ZJ, Zou L, Xiao SY, Micci MA, et al. Acute pancreatitis results in referred mechanical hypersensitivity and neuropeptide up-regulation that can be suppressed by the protein kinase inhibitor k252a. J Pain. 2003;4:329-37. (Pubitemid 37013024)
24. Friess H, Zhu ZW, di Mola FF, Kulli C, Graber HU, Andren-Sandberg A, et al. Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg. 1999;230:615-24. (Pubitemid 30191822)
25. Nakata K, Hosono Y, Hosono H, Sakaguchi H, Hosono S. The treatment of Kampo medicine for chronic pancreatitis. Jpn J Orient Med. 1986;36:25-43 (in Japanese with English abstract).
26. Su SB, Motoo Y, Xie MJ, Sakai J, Taga H, Sawabu N. Expression of pancreatitis-associated protein (PAP) in rat spontaneous chronic pancreatitis: effect of herbal medicine Saiko-keishi-to (TJ-10). Pancreas. 1999;19:239-47. (Pubitemid 29444997)
27. Su SB, Motoo Y, Xie MJ, Taga H, Sawabu N. Antifibrotic effect of the herbal medicine Saiko-keishi-to (TJ-10) on chronic pancreatitis in the WBN/Kob rat. Pancreas. 2001;22:8-17. (Pubitemid 32046208)
28. Gong HL, Tang WF, Yu Q, Xiang J, Xia Q, Chen GY, et al. Effect of severe acute pancreatitis on pharmacokinetics of Da-Cheng-Qi Decoction components. World J Gastroenterol. 2009;15:5992-9.
29. Liu HB, Huo HR, Guo JY, Li LF, Jiang TL. Effects of paeoniflorin on actin cytoskeletal changes of cultured rat brain microvessel endothelial cells stimulated by interleukin-1b. J US China Med Sci. 2006;3:31-9.
30. Yuan H, Ji WS, Wu KX, Jiao JX, Sun LH, Feng YT. Antiinflammatory effect of diammonium glycyrrhizinate in a rat model of ulcerative colitis. World J Gastroenterol. 2006;12: 4578-81. (Pubitemid 44256351)
31. Menegazzi M, Di Paola R, Mazzon E, Genovese T, Crisafulli C, Dal Bosco M, et al. Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol Res. 2008; 58:22-31.
32. Kao TC, Shyu MH, Yen GC. Glycyrrhizic acid and 18betaglycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. J Agric Food Chem. 2010;58:8623-9.
33. Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol. 2007; 14:431-41. (Pubitemid 46617319)
34. Oku H, Nakazato H, Horikawa T, Tsuruta Y, Suzuki R. Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin- 10 and protects mice from endotoxic shock. Eur J Pharmacol. 2002;446:167-76. (Pubitemid 34722571)
35. McMahon SB. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci. 1996;351:431-40. (Pubitemid 126745351)
36. Abe M, Akbar F, Hasebe A, Horiike N, Onji M. Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. J Gastroenterol. 2003;38:962-7. (Pubitemid 37455783)
37. Feng C, Wang H, Yao C, Zhang J, Tian Z. Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10 and IL-6-dependent manners. Int Immunopharmacol. 2007;7:1292-8. (Pubitemid 47126367)
38. Wu K, Zhang RL, Wang XP. The effects and mechanisms of glycyrrhizin on the TNBS-induced pancreatic fibrosis in rat. Chin Pharmacol Bull. 2003;12:1424-7 (in Chinese). (Pubitemid 38076065)